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licenses/by-nc-nd/4.0/).Summary The pathological spectrum of intraductal papillary neoplasm of bile duct (IPNB) remains to
be clarified. A total of 186 IPNBs were pathologically examined using the type 1 and 2 subclassifica-
tions proposed by Japanese and Korean biliary pathologists incorporating a two-tiered grading system
(low-grade and high-grade dysplasia), with reference to four subtypes (intestinal [i], gastric [g], pan-
creatobiliary [pb], and concocytic [o] subtype). IPNBs were classifiable into type 1 composed of low-
grade dysplasia and ‘high-grade dysplasia with regular structures’ (69 IPNBs), and type 2 of ‘high
grade dysplasia with irregular structures and complicated lesions’ (117 IPNBs). Type 1 was more com-
mon in the intrahepatic bile duct (78%), whereas type 2 was frequently located in the extrahepatic bile
duct (58%). Mucin hypersecretion was more common in type 1 (61%) than in type 2 (37%). IPNBs
were classifiable into the four subtypes: 86 iPNBs, 40 gIPNBs, 31 pbIPNBs, and 29 oIPNBs. The four
subtypes were histologically evaluable with reference to the type 1 and 2 subclassifications. iIPNB and
pbIPNBs were frequently classified as type 2, whereas types 1 and 2 were observed at similar rates int of Diagnostic Pathology, Fukui Prefecture Saiseikai Hospital, Wadanakacho Funahashi 7-1, Fukui, 918-8503, Japan
gmail.com (Y. Nakanuma).
1.002
hed by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
22 Y. Nakanuma et al.gIPNB and oIPNB. Stromal invasion was almost absent in type 1, irrespective of subtype, but was
found in 66 of 117 type 2 IPNBs (P < .01), and postoperative outcome was favorable in IPNBs without
invasion compared with IPNBs with invasion (P < .05). The type 1 and 2 subclassifications with refer-
ence to the four subtypes may provide useful information for understanding IPNB.
© 2021 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Since intraductal papillary neoplasm of bile duct (IPNB)
was proposed as a unique biliary tract neoplasm approxi-
mately 20 years ago, many studies have been reported,
revealing that IPNB is a unique preinvasive, grossly visible
neoplasm, frequently associated with invasive carcinoma,
but that is not homogeneous in its clinicopathological
features or molecular alterations [1e9].
Historically, IPNBs have been studied with reference to
and comparison with intraductal papillary mucinous
neoplasm of the pancreas (IPMN), because the biliary tract
and pancreas are located in close anatomic proximity and
some biliary diseases show similarities to pancreatic dis-
eases [5,6,10e14]. Interestingly, the neoplastic lining
epithelia of IPNB shows intestinal (iIPNB), gastric
(gIPNB), pancreatobiliary (pbIPNB), and oncocytic
(oIPNB) differentiation, as is observed in IPMN [1e3,14].
It became clear that IPNB shared several features with
IPMN but also differed from IPMN in its higher histolog-
ical grade, high frequency of associated invasive cancer,
worse prognosis, and some differences in the oncogenic
pathway [4e7,12e16]. Through these comparative studies,
IPNB is now being established as an independent disease
along the biliary tree [1,2,5,14].
Recently, a panel of Japanese and Korean biliary pa-
thologists proposed the consensus that IPNBs are sub-
classifiable into types 1 and 2 by supplementing a
traditional two-tiered grading system (low-grade and high-
grade dysplasia [LGD and HGD]) [17]. Type 1 IPNB is
characterized by regular structures, whereas type 2 shows
irregular structures, and foci of complicated lesions, such as
cribriform or solid structures, are frequently observed in
type 2. Although type 1 IPNBs share histologic features
with prototypic IPMNs, type 2 IPNBs are variably different
from IPMNs [1,5,14,17].
The World Health Organization published the Classifi-
cation of Digestive System Tumours 5th edition (2019), in
which the term IPNB was defined and described as a unique
preinvasive lesion of bile duct, and the type 1 and 2 sub-
classifications were only briefly and concisely introduced
[1]. Along with this publication, several studies using the
subclassifications have been published [8,15,18e20]. The
type 1 and 2 subclassifications were reproducible in these
studies. Most importantly, a multivariate analysis of factors
associated with long-term postoperative outcomes showedthat the subclassification was only significant factor and
that type 1 was associated with a favorable postoperative
outcome in comparison to type 2 [8,18]. In addition, type 1,
particularly iIPNB, frequently showed GNAS and KRAS
mutations, identical to those of IPMN, whereas type 2 did
not [8,19,21]. However, the precise pathological evaluation
of types 1 and 2, with reference to other pathological fea-
tures (including four subtypes), one of the characteristics of
IPNB, have not been discussed and remain to be clarified.
In addition, although tubular structures are not infrequent in
IPNBs, particularly gIPNB [1,15], the presence of tubular
components has not been discussed in IPNB with respect to
its diagnosis and subtyping. In fact, predominant tubular
components in intraductal papillary tumors have been re-
ported as an exclusion criterion of IPNB [22,23].
In this context, a pathological review of IPNB cases with
respect to the type 1 and 2 subclassifications is merited. For
this purpose, we collected 186 IPNBs, one of the largest
series of pathological studies of IPNB yet reported. This
study protocol was approved by the institutional review
board of Fukui Saiseikai Hospital (2019e036) and of
Shizuoka Cancer Center (T2020-71-2020-1-3).
2. Materials and methods
2.1. Pathologic definition of IPNB
IPNBs are defined as a grossly visible intraductal papillary
biliary neoplasm covering fine fibrovascular stalks in dilated
bile ducts and lacking an ovarian-type stroma [1,2]. This study
included cases with histologically predominant papillary or
villous lesions, as well as those with variable amounts of
tubular structure; exclusion criteria of IPNB because of
tubular-predominant features was not adopted [23,24]. IPNBs
associated with invasive carcinomas were included, because
invasion could develop as a natural course of IPNB and ‘IPNB
associated with invasive carcinoma’ is evaluable and recog-
nizable histologically [1,2].
2.2. Collection and preparation of tissue specimens
We collected a total of 180 cases with IPNB from many
institutions from Japan, Korea, and Thailand (the hospitals
from which these cases were obtained are shown in
the Acknowledgment). The cases showing considerable
amounts of two different subtype components within the
Intraductal papillary neoplasm of bile duct 23tumor like a collision tumor (n Z 3), and the cases showed
two different intraductal components of different subtypes
at different anatomical levels of the bile duct (n Z 3), were
examined separately. However, if more than two intraductal
tumors of the same subtype were found separately at
different anatomical levels, they were examined as a single
IPNB. When more than two subtypes were admixed in an
intraductal tumor, the predominant subtype was examined.
A total of 186 IPNB lesions from 180 cases were thus
examined.
As for backgrounds of IPNB, Thailand cases (nZ 34) had
a history of eating raw fish, suspicion of a history of liver
fluke infection by Opisthorchis viverrini (data cited from
[25]). In Japanese cases (n Z 135), a history of liver fluke
infection was not obtained, and two cases were associated
with hepatolithiasis. Both groups were compared in the pro-
portion of four subtypes and of types 1 and 2 classification.
The number of tissue blocks including the main tumor of
IPNB in individual cases ranged from 2 to 40. These blocks
were fixed in 10% neutral-buffered formalin and embedded
in paraffin. Data regarding the resected specimens and the
main clinical and laboratory data were available. While the
long term postoperative outcomes were available in 62
cases of Shizuoka Cancer Center, they were not available in
the remaining cases.
More than 20 serial thin sections were cut from each
formalin-fixed-paraffin-embedded-tissue block. Deparaffi-
nized sections were stained routinely. The remaining sections
were used for the immunohistochemical detection of MUC1,
MUC2, MUC5AC, MUC6, CDX2, CK7, and CK20. Other
antigens such as S100P were detected; however, the anti-
bodies and other reagents and staining methods applied in
individual hospitals were heterogeneous, and some immuno-
stained sections were not available at the time of the present
study. Thus, in this study, the immunostained sections were
only referenced at the time of subtyping, and no comparative
analyses were performed using these sections.Fig. 1 The intestinal subtype of intraductal papillary neoplasm of bile
fibrovascular stalks of low-grade dysplasia is growing regularly in the in
Type 2. Villous and papillary growth with intestinal epithelial morph
stratification and disordered polarity and stromal invasion of the duct w
magnification).2.3. Pathological examinations of IPNBs
2.3.1. A two-tiered grading: LGD and HGD
Based on cytoarchitectural alterations, particularly nu-
clear changes, intraductal IPNB tumors were graded as
LGD or HGD, as in other neoplastic precursor lesions in
the pancreas and biliary tract [1,2,26].
LGD is a neoplastic lesion lacking cellular and nuclear
pleomorphism, which shows mild nuclear hyperchromasia,
and small or medium cells and nuclei (Fig. 1A). Nuclear
stratification is not found, except in the case of iIPNB and
gIPNB (foveolar area). Nucleoli are not evident, except in
the case of oIPNB. The structures appear to be well-
organized.
HGD is a neoplastic lesion showing cellular and nuclear
enlargement and pleomorphism, nuclear hyperchromasia
and stratification, a thickened nuclear membrane, promi-
nent or evident nucleoli, and variable loss of cellular and
nuclear polarity. The presence of any HGD area in the
whole tumor indicates HGD [1,26]. Structures, such as
papillary, villous, and tubular (glandular) growth, are
relatively regular, and well-organized in some IPNBs, and
they were categorized as ‘HGD with regular structures’,
whereas in other IPNBs, their structures were irregular or
heterogeneous, with lesions categorized as ‘HGD with
irregular structures’ (Fig. 1B).
2.3.2. Type 1 and 2 subclassifications
Intraductal tumor is subclassified into types 1 and 2,
according to the type 1 and 2 subclassifications [1,14,17].
Type 1: (1) “Papillary” or “villous” or “tubular”
structural patterns are regular and appear homogenous and
well-organized (Fig. 1A). (2) Fibrovascular stalks are thin,
but not infrequently widened by edematous and inflam-
matory changes, particularly in the oncocytic subtype. (3)
This type is composed of LGD and ‘HGD with regular
structures.’duct (IPNB). A: Type 1. Awell-organized villous pattern with fine
trahepatic bile duct (HE staining ｘ70: original magnification). B:
ology showing irregular structures and nuclear hyperchromasia,
all (lower left). High-grade dysplasia. (HE staining ｘ70: original
24 Y. Nakanuma et al.Type 2: (1) “Papillary” or “villous” or “tubular” struc-
tural patterns are irregular and heterogeneous or not-well
organized (Fig. 1B). A serrated epithelial lesion as seen
in traditional serrated adenoma of the intestine [1] may be
found. (2) Relatively thin, but variably thickened fibro-
vascular stalks often associated with irregular or compli-
cated branching can be focally found. (3) Other lesions: (a)
foci of complicated structures, such as cribriform, solid and
compact tubular structures and variable-sized cystic
changes, (b) foci of bizarre cellular and nuclear changes
with the appearance of overt malignancy, (c) foci of other
types of carcinoma, such as neuroendocrine carcinoma, and
(d) coagulative necrosis can be detected. All cases of this
type belonged to ‘HGD with irregular structures.’
Type 1 is a prototype of each subtype of IPNB and re-
sembles the prototypic subtype of IPMN and colorectal
tubular, tubulovillous or villous adenoma. Type 2 can be
regarded as variably deviated from the prototype (type 1) of
IPNB.2.3.3. Classification into four subtypes
A total of 186 IPNBs were classified into four subtypes
based on the histological features and epithelial cell line-
ages [1,2,4,14]. Although their immunohistochemistry was
helpful, there were overlapping immunohistochemical
features in many cases.
2.3.3.1. Intestinal subtype (iIPNB). iIPNBs presented as
papillary or villous or tubular neoplasms showing an
intestinal epithelial differentiation. The lining epithelia
were characterized by tall, columnar epithelia with
single-layered or pseudostratified cigar-shaped enlarged
nuclei and basophilic or amphophilic cytoplasm with
varying apical vesicular mucin. The basic structures of
iIPNB were of villous, papillary, or tubular patterns.
Villous and papillary neoplastic epithelia covered the
fine fibrovascular stalks, and tubular neoplastic epithelia
were embedded in fibrous stroma. iIPNBs resembled the
prototypic subtype of iIPMN, as well as colorectal
tubular, or villous or tubulovillous adenoma.
Immunohistochemically, CDX2 was expressed in
almost all the cases examined, and CK20 was also
frequently expressed. MUC2 was expressed in goblet
cells.2.3.3.2. Gastric subtype (gIPNB). gIPNB presented with
regional growth of papillary and tubular (gladular)
neoplastic epithelia resembling gastric foveola epithelia
and pyloric glands, respectively. Immunohistochemically,
gIPNBs were positive for CK7. Although foveolar com-
ponents were positive for MUC5AC, and MUC6 could bedetected in the pyloric gland portions, their expression was
not exclusive, and both could be detected in the foveolar
and pyloric portions simultaneously.
2.3.3.3. Pancreatobiliary subtype (pbIPNB). pbIPNBs
showed many fine papillary structures with numerous fine
ramifying branches of thin fibrovascular stalks, as seen in
pbIPMN [1,2]. The structures and cellular patterns were
characterized by two features: (1) many branching, fine
papillary fibrovascular stalks with numerous ramifying
branches (fern-like) and (2) single-layered, small- to
medium-sized cuboidal or low-columnar, neoplastic-lining
epithelial cells, usually with centrally or basally located,
small- to medium-sized nuclei and pale or slightly
acidophilic cytoplasm. The cellular and nuclear sizes
resembled non-neoplastic biliary lining, simple epithelia.
Immunohistochemically, the lining epithelia were
frequently positive for CK7 and also for S100P and
MUC1. MUC5AC was frequently expressed, but not
constant. Staining of CDX2 and CK20 was negative.
2.3.3.4. Oncocytic subtype (oIPNB). oIPNBs were char-
acterized by single- to multilayered medium-sized cuboidal
to low-columnar epithelia with eosinophilic granular
cytoplasm referencing prototypic oIPMN [1,2]. In the
present study, oIPNBs showing small nuclei without
prominent nucleoli were considered LGD, whereas those
showing enlarged cells and hyperchromatic nuclei with
prominent nucleoli were considered HGD.
Immunohistochemically, CK7 and MUC5AC were
frequently but variably expressed, and MUC6 was not
infrequently expressed in the neoplastic epithelia.
2.3.4. The evaluation of other features of IPNBs
2 . 3 . 4 . 1 . A n a t o m i c a l l o c a t i o n a l o n g t h e b i l i a r y
tree. Extrahepatic IPNBs were located in the extrahe-
patic bileducts. Intrahepatic IPNBs were located within the
liver parenchyma and the bile ducts proximal to the right or
left hepatic ducts.
2.3.4.2. Mucin hypersecretion. .
2.3.4.3. Invasion. Colloid carcinoma, oncocytic car-
cinoma, and tubular adenocarcinoma were examined in the
invasive areas.
2.4. Statistical analyses
Statistical significance was determined using Student’s t-
test, a chi-squared test, and Fisher’s exact test. Estimates of
overall survival were calculated using the KaplaneMeier
method using 62 cases of IPNB experienced in Shizuoka
Cancer Center. That is, overall survival between IPNBs with
invasion (33 cases) and without invasion (29 cases), between
LGD (2 cases) and HGD (27 cases) without invasion, and
Table 1A Main clinicopathological features of type 1 and 2
subclassifications of a total of 186 intraductal papillary
neoplasm of bile duct (IPNB) lesions.
Intraductal papillary neoplasm of bile duct 25between type 1 (12 cases) and type 2 (17 cases) without in-
vasion were compared using the long-rank test. P values of
<.05 were considered to indicate statistical significance.Type 1 Type 2
Number of lesions (%) 69 (37%) 117 (63%)
Age (years): mean and range 66:46e82 67:34e903. Results
Male:Female 42:27 81:36
%, percentage of lesions. All but one autopsy case were surgically
resected cases. Two Japanese cases had a history of preceding hep-
atobiliary diseases (alcoholic fibrosis and chronic hepatitis C), whereas
the cases from Korea and Thailand had a clinical history of eating
habits suggestive liver fluke infestation [25]. There were no significant
differences in the age or sex distribution between two
subclassifications.3.1. Prevalence of type 1 and 2 subclassifications
and of LGD and HGD
In 186 IPNBs, type 2 (63%) was common in comparison
with type 1 (37%) (Table 1A).Most IPNBs were HGD (90%),
whereas only 10% belonged to LGD (Table 1B). IPNBs of
HGD (n Z 167) was composed of ‘HGD with regular struc-
tures’ (30%) and ‘HGDwith irregular structures’ (70%). Type
1 IPNB was composed of LGD (19 cases) and ‘HGD with
regular structures’ (50 cases), whereas type 2 IPNB of only
‘HGD with irregular histologies.’3.2. Characterization of four subtypes with respect
to the type 1 and 2 subclassifications
iIPNB was most common, followed by gIPNB, pbIPNB,
and oIPNB (Table 1C).Fig. 2 The intestinal subtype of intraductal papillary neoplasm of bil
irregular tubular (glandular) pattern with thin stroma in the bile duct. Th
The surrounding mucosa also shows an intraepithelial, noninvasive mi
cation). B: A high-power view of “A” reveals nuclear hyperchromasia, s
as complicated lesions, such as a cribriform pattern (*). High-grade dy3.2.1. Histological characteristics of the four subtypes
with respect to types 1 and 2
Histopathologies of four subtypes were evaluable based
on type 1 and 2 subclassifications (a modified two-tiered
grading system) as follows:
3.2.1.1. Intestinal IPNB (n [ 86). In type 1 (n Z 28), the
structures of villous/papillary, tubular patterns were regular
(Fig. 1A), whereas in type 2 (n Z 58), they showed
irregular, heterogeneous lesions with focally widenede duct (IPNB). Type 2. A: This tumor is mainly composed of an
e neoplastic tubules are pleomorphic in size, and some are cystic.
cropapillary neoplasm (/) (HE staining 50: original magnifi-
tratification and disordered polarity of glandular epithelia, as well
splasia (HE staining 150: original magnification).
Table 1B Correlation between distribution of low-grade dysplasia (LGD) and high-grade dysplasia (HGD) and that of type 1 and 2
subclassifications in a total of 186 intraductal papillary neoplasm of bile duct (IPNB) lesions.
Type 1 IPNBs (n Z 69) were composed of LGD lesions (n Z 19) and of ‘HGD lesions with regular structure’ (nZ 50), whereas type 2
IPNBs (nZ 117) were composed of only ‘HGD with irregular structures’ (nZ 117). This means that 50 of IPNBs with HGD (nZ 167)
were classified as type 1 (‘HGD with regular structures’) and the remaining 117 IPNBs were classified as type 2 (‘HGD with irregular
structures’).
26 Y. Nakanuma et al.fibrovascular stalks or stroma (Figs. 1B, 2A and 2B). The
nuclei were enlarged, along with their nucleoli, and the
supranuclear vesicular mucinous appearance was
decreased in type 2. Regarding the predominant
structures, 27 IPNBs (all type 1) were mainly composed
of villous/papillary pattern (more than two-thirds),
whereas 10 IPNBs (1 type 1, n Z 1; type 2, n Z 9) had
a mainly tubular pattern (more than two-thirds). The
remaining 49 lesions (all type 2) were composed of
mixed papillary/villous and tubular components (each
more than one-third).
3.2.1.2. Gastric IPNB (n [ 40). In type 1 (n Z 19), the
basic structures of the gIPNB showed a
regional distribution of neoplastic areas resembling theFig. 3 The gastric subtype of intraductal papillary neoplasm of bile
resembling gastric foveola are seen in the bile duct with excessive mucu
Beneath the papillary patterns of the surface, there are many glandular
duct. Inset: Glandular structures are evident (HE staining 100; original
components in the bile duct. Foveolar and pyloric gland differentiation b
100: original magnification).gastric foveola (Fig. 3A) and those resembling pyloric
glands (Fig. 3B) in variable proportions. The foveolar
area was composed of columnar to low columnar cells
with basally oriented, single-layered or pseudostratified
nuclei and abundant supranuclear pale vesicular mucinous
cytoplasm lining the thin fibrovascular stalks. The pyloric
gland components were arranged as glandular structures
embedded in a few fibrous stroma with cuboidal or low
columnar epithelia, basally located nuclei and abundant
clear supranuclear cytoplasm. In type 2 (n Z 21), the
two component patterns were irregular or immature.
Recognition of the transition between the foveolar regions
and pyloric gland region were not infrequently
controversial (Fig. 3C). The lining epithelial cells of the
foveolar components were composed of low to tallduct (IPNB). Type 1. A: Type 1. Papillary lesions with features
s secretion (HE staining 100; original magnification). B: Type 1.
(tubular) components resembling gastric pyloric glands in the bile
magnification). C: Type 2. Papillary lesions with tubular or acinar
ecome vague, and stromal invasion was also found (*) (HE staining
Fig. 4 The pancreatobiliary subtype of intraductal papillary neoplasm of bile duct (IPNB). A: Thin ramification of papillary branches
lined by a single layer of epithelia. Inset: The lining epithelia with a single layer of nuclei resemble bile duct epithelia. Type 1, high-grade
dysplasia (HE staining 70: original magnification). B: Fine fibrovascular branches lined by atypical and papillary epithelia showing
stratification and disordered polarity. Type 2, high-grade dysplasia (HE staining 200: original magnification).
Intraductal papillary neoplasm of bile duct 27columnar epithelia with basally located, enlarged,
hyperchromatic and anisocytotic nuclei and clear
cytoplasm. Regarding the pyloric gland components,
irregularly shaped papillary patterns with single-layered
nuclei, or variably sized cystic changes with clear
cytoplasm were also found. Structurally, 8 gIPNBs (type
1, n Z 5; type 2, n Z 3) were pyloric-gland-like pattern-Fig. 5 The oncocytic subtype of intraductal papillary neoplasm of bile
with slit-like lumina. Type 1, low-grade dysplasia (HE staining 150: o
with intratumoral lumina and disordered structures. Type 2, high-gradepredominant, 23 IPNBs (type 1, n Z 8; type 2, n Z 15)
were foveola-like pattern-predominant, and the remaining
9 lesions (type 1, n Z 4; type 2, n Z 5) were mixed
foveola-pyloric gland-like patterns.
3.2.1.3. Pancreatobiliary IPNB (n [ 31). In type 1
(n Z 6), many fine papillary structures with numerous fineduct (IPNB). A: Compact growth composed of oncocytic epithelia
riginal magnification). B: Compact growth of oncocytic epithelia
dysplasia (HE staining 200: original magnification).
28 Y. Nakanuma et al.ramifying branches of thin fibrovascular stalks were ho-
mogeneous and regular throughout the tumor (Fig. 4A),
whereas in type 2 (n Z 25), papillary architectures with
numerous irregular branching patterns, usually lined by
single-layered or mild-stratified medium to large cells
with hyperchromatic nuclei and prominent nucleoli, were
irregular (Fig. 4B). Although fibrovascular stalks were
usually fine, these stalks were occasionally widened at
the basal side, and some areas were associated with
suspected foci of stromal invasion of carcinoma.
3.2.1.4. Oncocytic IPNB (n [ 29). In type 1 (n Z 16),
“papillary lesions” of single- to multilayered lining
epithelia on fibrovascular stalk or “compact growth” of
neoplastic epithelia with regular secondary lumina on thin
fibrovascular or edematously widened stalks were found
(Fig. 5A). The neoplastic lining epithelia of both patterns
were medium-sized cells with relatively substantial,Fig. 6 The proportion of type 1 and 2 intraductal papillary
neoplasms of bile duct (IPNBs) in four subtypes. In gastric IPNB
(gIPNB) and oncocytic IPNB (oIPNB), the proportion of types 1
and 2 were similar (approximately 50%), whereas intestinal IPNB
(iIPNB) and pancreatobiliary IPNB (pbIPNB) were more
frequently classified as type 2 than as type 1. There were signif-
icant differences in the proportions of types 1 and 2 between
pbIPNB and gIPNB or oIPNB. n: number of IPNB lesions. *,
P < .05.oncocytic and finely granular cytoplasm and small nuclei
with small nucleoli. Foci of neoplastic epithelia of gastric
subtypes were not infrequently found, particularly in
“papillary lesions.” Cytoplasmic hyalines were
occasionally encountered in both patterns. Type 2
(n Z 13) showed irregular “papillary lesions” and
“compact” larger cells and nuclei with prominent nucleoli
covering thin or edematous, inflammatory fibrovascular
stroma. Fibrovascular stalks became irregular, and
secondary lumina became irregular or ectatic and
contained mucin (Fig. 5B).
3.2.2. Relationship between type 1 and 2
subclassifications and the four subtypes
As shown in Fig. 6, in iIPNB and pbIPNB, type 2 (68%
and 81%) was more frequently observed than type 1,
whereas in gIPNB and oIPNB, types 1 (48% and 55%) and
2 (52% and 45%) were observed with similar frequency.
Type 2 was significantly predominant in pbIPNB in com-
parison with gIPNB and oIPNB (both P < .05).3.3. The prevalence of other features in IPNB with
respect to the type 1 and 2 subclassifications
3.3.1. Location along the biliary tree
Overall, IPNBs were slightly frequent in the intrahepatic
(55%) than in the extrahepatic bile duct (45%) (Fig. 7). As
for the subclassifications, type 1 IPNBs were common in
the intrahepatic (78%), whereas type 2 were frequent in the
extrahepatic bile ducts (58%) (P < .01). As for four sub-
types, iIPNBs and pbIPNBs were frequent in the extrahe-
patic, whereas gIPNB and oIPNB were frequent in the
intrahepatic bile duct. There were significant differences in
the intrahepatic and extrahepatic predominance between
iIPNB and gIPNB or oIPNB, and between pbIPNB and
gIPNB or oIPNB.
3.3.2. Mucus hypersecretion
Overall, 46% of 186 IPNBs showed mucus hypersecre-
tion (Fig. 8). As for the type 1 and 2 subclassifications, 61%
of the type 1 IPNBs (n Z 69) showed mucus hypersecre-
tion, whereas only 37% of the type 2 IPNBs (n Z 117)
showed mucus hypersecretion (P < .01). As for the four
phenotypes, mucus hypersecretion was most common in
gIPNBs (72.5%), followed by oIPNB (72.4%), iPNB
(34%), and pbIPNB (19%). There were significant differ-
ences between gIPNB and iIPNB or pbIPNB and between
oIPNB and iIPNB or pbIPNB.
3.3.3. Occurrence of complicated lesions, bizarre cells or
nuclei, and coagulation necrosis
Foci of complicated lesions, bizarre cells or nuclei, and
coagulative necrosis were only found in type 2 IPNBs
(52%, 19%, and 29%, respectively; Fig. 9). Neuroendocrine
carcinoma was only found in one case of type 2 IPNB.
Intraductal papillary neoplasm of bile duct 293.3.4. Stromal invasion
Stromal invasion (Figs. 1B and 3C) was found in 38% of
the 186 IPNBs (Fig. 10). As for the subclassification, type 2
showed frequent stromal invasion (56%), whereas type 1
showed invasion (6%) (P < .01). As for individual sub-
types, stromal invasion was most frequent in pbIPNB
(65%), followed by iIPNB (35%), oIPNB (28%), and
gIPNB (25%). Such invasion was more frequent in pbIPNB
than in either of the other subtypes (P < .01). The invasive
parts of all pbIPNBs and gIPNB showed tubular carcinoma,
while that of oIPNB showed oncocytic adenocarcinoma
except for one case showing mixed colloid and tubular
adenocarcinoma. While 27 iIPNBs showed invasive tubular
adenocarcinoma, 2 iIPNBs mixed colloid and tubular
adenocarcinoma, and one iIPNB predominantly colloid
carcinoma.3.3.5. Postoperative survival
As shown in Fig. 11, IPNBs without invasion showed
favorable postoperative outcome in comparison with IPNBs
with invasion (P < .05). However, there was no statistical
difference in noninvasive IPNBs between LGD and HGD
(P > .05) and between types 1 and 2 (P > .05).Fig. 7 The distribution of intraductal papillary neoplasms of bile duct
(tIPNBs, n Z 186), overall, were slightly frequently located in the int
(n Z 83). Type 1 IPNBs were frequently located in the intrahepatic bile
ducts (P < .01). Intestinal IPNB (iIPNB) and pancreatobiliary IPNB (pb
gastric IPNB (gIPNB) and oncocytic IPNB (oIPNB) were preferentia
differences between gIPNB and iIPNB or pbIPNB, and between oIPNB a3.3.6. Suspected backgrounds
There were no statistical significance in the proportion
of four subtypes and type 1 and 2 subclassifications be-
tween Japan and Thailand cases (Table 1D).4. Discussion
The findings obtained are summarized as follows: (1)
based on the LGD and HGD status and structural regular-
ities and complicated lesions, IPNBs were subclassified
into types 1 (37% of all IPNBs) and 2 (63%). (2) Type 1
was common in the intrahepatic bile ducts and frequently
showed mucin hypersecretion, whereas type 2 was frequent
in the extrahepatic bile ducts and frequently showed stro-
mal invasion. The type 1 and 2 subclassifications may
provide useful information for understanding IPNB.
Although a two-tiered grading system (LGD and HGD)
is used for the precursor lesions in the pancreatobiliary
system [1,2,26], all or almost all IPNBs are classified as
HGD or carcinoma in situ [8,27e29]. In the present study,
90% of IPNBs were classified as HGD and only the
remaining 10% classified as LDG. This marked deviation
of IPNB toward HGD and the possibility of sampling error(IPNBs) in the intrahepatic and extrahepatic bile duct. Total IPNBs
rahepatic bile duct (n Z 103) than in the extrahepatic bile ducts
duct, whereas type 2 IPNBs were frequent in the extrahepatic bile
IPNB) were similarly distributed between both bile ducts, whereas
lly located in the intrahepatic bile ducts. There were significant
nd pbIPNB or iIPNB. n, number of IPNB. *, P < .05; **, P < .01.
Fig. 8 The incidence of mucin hypersecretion in intraductal papillary neoplasms of bile duct (IPNBs). About half of total IPNBs (tIPNBs,
n Z 186) showed mucin hypersecretion. As for the type 1 and 2 subclassifications, type 1 IPNB showed mucin hypersecretion more
frequently than type 2 IPNBs (P < .01). Gastric IPNB (gIPNB) showed mucin hypersecretion most frequently, followed by oncocytic IPNB
(oIPNB), intestinal IPNB (iIPNB), and pancreatobiliary IPNB (pbIPNB). There were significant differences between gIPNB and iIPNB or
pbIPNB, and between oIPNB and pbIPNB or iIPNB. n, number of IPNBs. **, P < 0.01.
Table 1C Main clinicopathological features of intraductal
papillary neoplasm of bile duct (IPNB) in a total IPNBs and in
four subtypes of IPNB, respectively.
tIPNB iIPNB gIPNB pbIPNB oIPNB




















Male:Female (%) 122:64 60:26 27:13 19:12 16:13
A total of 186 IPNBs were subtyped into four subtypes. tIPNB, total
IPNB; iIPNB, intestinal subtype of IPNB; gIPNB, gastric subtype of
IPNB; pbIPNB, pancreatobiliary subtype of IPNB; oIPNB, oncocytic
subtype of IPNB. There were no significant differences in the age or
sex distribution among four subtypes.
30 Y. Nakanuma et al.suggest the supplementation of a two-tiered system to grade
IPNBs. This study showed that the type 1 and 2 sub-
classifications [1,17] were actually applicable in a large
number of IPNBs and could be supplementary. In fact, this
subclassification system was reproducible in several studies
[8,15,18e20].
Through this review of the largest number of IPNBs,
iIPNB was found to be the most common subtype, followed
by gIPNB, pbIPNB, and oIPNB, and the four subtypes were
then examined with reference to the type 1 and 2
subclassifications.
iIPNBs structurally showed (1) papillary/villous pre-
dominant, (2) tubular-predominant, and (3) mixed papil-
lary/villous and tubular type. Villous/papillary
predominant-iIPNB resembled iIPMN and colorectal
villous adenoma. In contrast, tubular-predominant iIPNB,
which is not recognized in iIPMN [1,2], resembled colo-
rectal tubular adenoma. In high-grade colorectal tubular
neoplasms, “papillary structures” develop structurally,
along with tubular components [1]: mixed villous/papillary
and tubular-type iIPNB may reflect or recapitulate featuresof high-grade colorectal tubular adenoma. Serrated IPNB
lesions also mimicked traditional serrated adenoma of the
intestine [1].
Our recent study [15] showed that two components
suggestive of gastric foveola (eg, papillary epithelia) and
Fig. 9 The incidence of complicated lesions (cribriform and solid lesions, and variable-sized cystic lesions), bizarre cellular and nuclear
changes, and coagulation necrosis in intraductal papillary neoplasms of bile duct (IPNB). These three categories of lesions were found in
61, 22, and 34 IPNB lesions, respectively, in tIPNBs (n Z 186). These lesions were only detected in type 2 cases but not in type 1 cases. n,
number of cases.
Intraductal papillary neoplasm of bile duct 31pyloric glands (eg, tubular epithelia) were found regionally
in gIPNB, and the transition of both components was
recognizable at several points. The present study showed
that the pyloric gland-predominant type was most common,
followed by the foveola-predominant type and mixed py-
loric gland-foveola type. The pyloric gland-predominant
gIPNB and gIPMN may correspond to previously re-
ported intraductal tubular neoplasms or pyloric gland ade-
noma of the pancreatic ducts and pyloric gland adenoma or
tubular adenoma of the bile duct [22,30,31].
There were at least two defining characteristics of
pdIPNB: (1) many fine papillary structures and numerous
ramifying branches with thin fibrovascular stalks and (2) a
simple cuboidal and low-columnar epithelium with cen-
trally or basally located nuclei resembling the lining
epithelia of the bile duct. In this series, all pbIPNBs were
classified as HGD. The differentiation of type 2 pbIPNB
from other subtypes of type 2 was controversial in some
cases because the cytological features of pancreatobiliary
differentiation were not characteristic in comparison with
other subtypes.
oIPMNs have been reported to present cast-like growth
in the pancreatic ducts and rarely show mucus hyperse-
cretion [1,2], and their genetic changes also differ fromthose of other subtypes of IPMN; thus, oIPMN was recently
recognized as a distinct entity from the other three subtypes
of IPMN [1]. However, oIPNB frequently presented with
excessive mucin secretion in this study, suggesting that a
difference in the biological features of oIPMN and oIPNB.
Recently, mucin- and MUC5AC-negative intraductal
tubulopapillary neoplasms (ITPNs) and MUC5AC-positive
intraductal tubule-forming biliary neoplasm were reported
[22,23]. In those cases, tubule predominance was a criterion
used to exclude a diagnosis of IPNB. However, this study
suggested that tubule (gland)-predominant and mixed
tubular-villous IPNBs, in addition to papillary/villous-
predominant IPNBs, may be a part of the spectrum of
gIPNB as well as of iIPNB. In this context, MUC5AC-
positive biliary intraductal papillary neoplasm and other
intraductal tubular neoplasms showing gastric and intesti-
nal differentiations could be included in the spectrum of
gIPNB and iIPNB.
Regarding the distribution along the biliary tree, IPNBs
overall were slightly frequent in the intrahepatic bile ducts.
Type 1 was frequent in the intrahepatic, whereas type 2 was
frequent in the extrahepatic bile ducts. iIPNB and pbIPNB
were frequently found in the extrahepatic bile ducts,
whereas gIPNB and oIPNB were frequent in the
Fig. 10 The incidence of stromal invasion by intraductal papillary neoplasms of bile duct (IPNBs). Stromal invasion was found in 70 of
the 186 in total IPNBs (tIPNBs). As for the type 1 and 2 subclassifications, 56% of the type 2 IPNBs showed stromal invasion, whereas only
6% of the type 1 IPNBs showed invasion (P < .01). Pancreatobiliary IPNB (pbIPNB) showed stromal invasion most frequently (22 of 31
cases), followed by intestinal IPNB (iIPNB), oncocytic IPNB (oIPNB), and gastric IPNB (gIPNB). There were significant differences
between pbIPNB and oIPNB, gIPNB or iIPNB. **, P < .01.
32 Y. Nakanuma et al.intrahepatic bile ducts. The four subtypes IPMNs are also
reported to show preferential anatomical locations [1,2]:
gIPMNs are almost always found in the branch pancreatic
duct, whereas iIPMNs are frequent in the main pancreatic
duct. The anatomy may influence the development of IPNBTable 1D Proportion of subtypes and type 1 and 2 sub-






Intestinal (n Z 75) 58 (43%) 17 (50%)
Gastric (n Z 37) 30 (22.2%) 7 (21%)
Pancreatobiliary (nZ 29) 26 (19.3) 3 (8.8%)
Oncocytic (n Z 28) 21 (15.6%) 7 (21%)
Type 1 and 2
subclassifications
Type 1 (n Z 51) 37 (27.4%) 14 (41.2%)
Type 2 (n Z 118) 98 (72.6%) 20 (58.8%)with the four subtypes, as well as the type 1 and 2 sub-
classifications, as is observed in IPMN.
This study demonstrated that mucin hypersecretion was
common in type 1 but uncommon in type 2, and stromal
invasion was frequent in type 2, but rare in type 1. Mucin
hypersecretion is known to be more common in intra-
hepatic IPNBs than in extrahepatic IPNBs [4,7,32], and was
relatively common in gIPNB and oIPNB. Stromal invasion,
which is reported to be more common in the extrahepatic
IPNB than in the intrahepatic IPNB, was relatively frequent
in pbIPNB, which was prevalent in the extrahepatic bile
duct. Taken together, the anatomic location of types 1 and 2
IPNB may influence several phenotypes of IPNB and
reflect a postoperative prognosis in comparison to type 1
[8,18].
Thailand cases with a history of eating low fish, possible
indicative of O. viverrini infection [25] and Japanese cases
with no history of liver fluke but few occasional hep-
atolithiasis showed similar distribution of type 1 and 2
subclassifications and of four subtypes, suggesting that
these background factors may not to be related to the
development of these features of IPNB.
Fig. 11 Kaplan-Meier survival curves for cohorts of patients with (33 cases) and without invasion (29 cases), for non-inasive IPNBs with
low-grade (2 cases) and high-grade dysplasia (27 cases) and for non-invasive IPNBs with type 1 (12 cases) and type 2 (17 cases). A: IPNBs
without invasion showed a favorable outcome than those with invasion (P Z .0172). B: There was no difference in noninvasive IPNBs
between low-grade and high-grade dysplasia (PZ .343). C: As for type 1 and 2 IPNBs without invasion, there was no significant difference
(P Z .761), while type １ seems to show a favorable course until 5 years.
Intraductal papillary neoplasm of bile duct 33IPNBs and IPMNs share several features [10,14].
Mucin hypersecretion is common in both IPNBs and
IPMNs, whereas it is not constantly in IPNBs [1,6,10,24].
In addition, almost all cases of gIPMN are classified as
LGD [1,2], whereas 20% and 25% of gIPNBs were
classified as HGD and showed stromal invasion, and
iIPNBs were composed of villous/papillary-predominant,
tubular (glandular)-predominant and mixed villous/papil-
lary mixed growth patterns, similar to those in colorectal
adenomas, whereas iIPMN only showed villous differen-
tiation [1,2]. Most iIPMNs show GNAS and KRAS muta-
tions [1,2]. However, although iIPNBs with a villous
pattern showed genetic features similar to those of
iIPMNs, other iIPNBs showed other genetic alterations,
such as TP53 and PIK3CA mutations [21]. Furthermore,
in IPMNs, colloid carcinoma was a relatively common
finding in areas of invasion [1,2], although this lesion was
rare in IPNBs. Molecular and genetic studies targeting thedifferences between IPNB and IPMN may provide
important information on the development of IPNB and
also IPMN [10].
As for the factors related to postoperative course of
IPNBs, Gordon-Weeks et al. reported a significantly worse
prognosis for IPNB with invasion [33], and this was
reproduced in this study. Recent several studies analyzing
the postoperative course of IPNBs using many cases
[8,20,29] revealed that type 1 showed favorable post-
operative outcomes in comparison with type 2, suggesting
that this subclassification may be applicable in the clinical
evaluation of IPNBs. However, in this study, the significant
better prognosis was not obtained in type 1, probably
because the number of cases examined was too small.
Several molecular and genetic studies on type 1 and 2
IPNBs [8,9,19e29,34] showed KRAS and GNAS mutations
enriched in type 1, whereas TP53, SMAD4, and KMT2C
mutations enriched in the type 2 [8,19].
34 Y. Nakanuma et al.The main limitations of this study were that the IPNB
cases that were included in the present study included both
hospital cases and consultation cases, raising the possibility
of bias in this study. The results of molecular and genetic
analyses were not available in this study. The subtyping of
IPNB could be informative but detailed immunohisto-
chemistries were limited in routine practice.
5. Conclusions
IPNBs were classifiable into the type 1 and 2 sub-
classifications based on structural regularities and the
occurrence of complicated lesions. Types 1 and 2 show
different clinicopathological features. The former
frequently showed mucin hypersecretion and rarely showed
stromal invasion, whereas that latter infrequently showed
mucus hypersecretion and frequently showed stromal in-
vasion and unfavorable postoperative outcome. Examina-
tion of invasion and two-tiered grading supplemented by
type 1 and 2 subclassifications may give important infor-
mation, and the recognition of type 1 and 2 IPNBs may
improve the understanding of IPNBs.
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